Effective May 27, 2024: Clinical Policies
Date: 05/22/24
Superior HealthPlan has updated certain clinical policies to ensure medical necessity review criteria is current and appropriate for members and the scope of services provided. As a result, the following policies are effective on May 27, 2024, at 12:00AM.
Changes in these policies reflect preauthorization requirement amendments that are less burdensome to insureds, physicians, or health care providers.
POLICY  | APPLICABLE PRODUCTS  | NEW POLICY OVERVIEW OR UPDATED POLICY REVISIONS  | 
| 
 (CP.MP.57)  | Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP, and Ambetter  | Policy updates include: 
  | 
Pediatric Kidney Transplant (CP.MP.246)  | Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP, and Ambetter  | Policy updates include: 
  | 
Skin and Soft Tissue Substitutes for Chronic Wounds (CP.MP.185)  | Ambetter  | Policy updates include: 
  | 
To review all policies, please visit Superior’s Clinical, Payment & Pharmacy Policies webpage.
Prior to updates, Medical Clinical policies are reviewed and approved by the Utilization Management Committee.
For questions or additional information, contact Superior’s Prior Authorization department at 1-800-218-7508.